Inventor profile of:

Arthur E. Warrington

City:

Rochester, Minnesota

Country:

United States

Published Applications:

11

Last publication date:

2022-05-05

Top Assignees for applications by Arthur E. Warrington

The entities that hold a legal rights for patent applications filed by inventor Warrington Arthur E.:

Recent patent applications by Warrington Arthur E.

Arthur E. Warrington from Rochester, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-05
US20220135659A1
Chemistry; metallurgy

TREATMENT OF NEONATAL HYPOXIA INCLUDING IMPAIRMENTS OR EFFECTS THEREOF

#2 | 2020-12-24
US20200397898A1
Human necessities

HUMAN ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASE

#3 | 2020-08-06
US20200247883A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS INCLUDING A RECOMBINANT HUMAN MAB THAT PROMOTES CNS REMYELINATION

#4 | 2018-06-28
US20180179277A1
Chemistry; metallurgy

Compositions and Methods including a Recombinant Human MAB that Promotes CNS Remyelination

#5 | 2017-12-14
US20170355754A1
Chemistry; metallurgy

Treatment of neonatal hypoxia including impairments or effects thereof

#6 | 2015-10-22
US20150299316A1
Chemistry; metallurgy

Compositions and methods including a recombinant human MAB that promotes CNS remyelination

#7 | 2015-04-16
US20150104460A1
Chemistry; metallurgy

Human Antibodies and Specific Binding Sequences Thereof for use in Stroke and Ischemia or Ischemic Conditions

#8 | 2013-11-21
US20130309240A1
Human necessities

Compositions and methods including a recombinant human MAB that promotes CNS remyelination

#9 | 2013-10-24
US20130280167A1
Human necessities

HUMAN ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASE

#10 | 2011-02-03
US20110027288A1
Chemistry; metallurgy

HUMAN MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN, AND THEIR USE AS THERAPEUTIC AGENTS

#11 | 2007-04-19
US20070086999A1
Chemistry; metallurgy

Compositions and methods including a recombinant human MAB that promotes CNS remyelination

InventorID:

496504 ⎘